The occurrence of acid mucopolysaccharides in human thrombocytes has been reported from this laboratory ( 1 ) . The present continuing study had as its purpose further qualitative characterization and a study of the amounts of the acid mucopolysaccharides present in thrombocytes of patients with rheumatoid arthritis as compared to nonarthritic individuals. Because of the acidic nature of the mucopolysaccharides, it was proposed further to measure the amount of 5-hydroxytryptamine present in the same thrombocyte preparations, to determine if any correlation might exist in the content of these two classes of substances.
The overall results of the qualitative studies suggested the probability that a mixture of acid mucopolysaccharides is present in human thrombocytes. The amount present in thrombocytes per unit of blood was significantly greater in patients with nonrheumatoid inflammatory processes than in the control group, but the amount present per unit of thrombocytes was essentially the same in all categories of patients studied. There was no correlation between amount of acid mucopolysaccharides and amount of 5-hydroxytryptamine in human thrombocytes in the present study.
EXPERI M ENTS
Blood was obtained by venipuncture from hospitalized patients,' using siliconed syringes and dispensing rapidly in approximately 9 ml. amounts to siliconed tubes containing 1 ml. of 1 per cent disodium ethylenedinitrilo tetraacetate (Eastman.) in 0.7 per cent aqueous sodium * This work was supported by grants from the National Institute of Arthritis and Metabolic Diseases of the National Institutes of Health, United States Public Health Service; and the American Heart Association.
1 As in previous investigations (2), three groups of patients were studied. The groups were as previously defined and consisted essentially of Group A with no evidence of inflammatory disease, Group B with significant but nonrheumatoid inflammatory processes and Group C with unequivocal active rheumatoid arthritis. chloride solution. The blood level in each tube was marked before centrifuging, after which thrombocytes were separated from the blood by the method of Dillard, Brecher and Cronkite (3). The volume of blood used was measured accurately by replacement to mark on the finally emptied tubes, correcting for known volume of anticoagulant; the blood sample usually totaled 50 to 60 ml. from each patient.
The thrombocyte buttons were drained after second centrifuging and the inner walls of each tube were wiped dry with gauze. Saline wash was omitted to avoid trauma to and loss of thrombocytes in a third centrifuging. The thrombocytes were resuspended smoothly2 in 25 ml. 0.14 M NaCl in 0.02 M NaOH. Partial disruption of thrombocytes started spontaneously on brief standing at room temperature and was completed by sonication in a Raytheon Sonic Oscillator at 9 KC. per second for 10 minutes. Duplicate 9 ml. aliquots of the clear sonicate were then carried through perchloric acid precipitation and the subsequent steps for recovery of acid mucopolysaccharides by the method of Bollet, Seraydarian and Simpson (4), the final hexuronic acid content of the fraction being determined by the carbazole color reaction of Dische (5). A 0.5 ml. aliquot of the sonicate was used for biuret determination by the method of Jayle, Boussier and Badin (6).3 Duplicate 3 ml. ali--Preparations uniformly resuspended smoothly. Clumping occurred only with damaged thrombocytes and such preparations were discarded. 3 Biuret determination (expressed as mg. of standard human serum albumin, A.R.C., Squibb) was used as a method for quantitation of thrombocytes in the present study to circumvent the inaccuracies inherent in methods for counting thrombocytes. Since the study was a comparative one, the use of a standard method for recovery of thrombocytes introduced a fairly uniform factor of loss in recovery into all groups. The amount of biuret positive material found in thrombocytes from 100 ml. of blood was of an order of magnitude comparable to that observed by the others [summarized by Zucker and Borreli (7)], on conversion of their data from protein nitrogen per unit of thrombocytes to protein content per usual number of thrombocytes in 100 ml. of normal blood. The likelihood of significant contamination of thrombocytes with traces of plasma was discounted since biuret determinations on 1: 100 dilutions of plasma supernates revealed no significant differences in plasma biuret level between the three groups studied, in contrast to the sig-quots of the sonicate were used for extraction of 5-hydroxytryptamine using the fluorometric method of Udenfriend, Weissbach and Clark (8) , with final extraction into 0.1 N hydrochloric acid and measurement of 5-hydroxytryptamine by use of an Aminco Spectrophotofluorometer with activation at 295 m/A and fluorescence at 335 m,0. Standards of 1, 2 and 3 ,ug. of serotonin creatinine sulfate (kindly furnished by Abbott Laboratories), were run through the entire extraction procedure with every determination and recovery from thrombocytes was calculated from the standard curve obtained, converting the final values to 5-hydroxytryptamine. 4 Thrombocytes used for additional biochemical studies were prepared as for the determination of hexuronic acid by the carbazole method. Using thrombocytes prepared from a patient with no evidence of inflammatory disease, hexuronic acid was determined in parallel by the carbazole method and by a modification of the orcinol method of Brown (9) . In each of two other similar thrombocyte preparations, parallel determinations were made of the hexuronic acid content by the carbazole method and of the hexosamine content by a modification (10) of the method of Elson and Morgan.
To test the susceptibility of the thrombocyte fraction to hydrolysis by testicular hyaluronidase, thrombocytes from a patient with peptic ulcer were carried through the sonication step noted previously. One aliquot was then incubated for 255 minutes at 370 with 600 units of Alidase® (Schering Corp., commercial testicular hyaluronidase), as were control preparations of a thrombocyte aliquot in buffer and Alidase® in buffer. All preparations were then carried through perchloric acid precipitation, dialysis against running water and the subsequent steps of the Bollet procedure for recovery of acid mucopolysaccharides.
For paper chromatography of acid mucopolysaccharides, thrombocytes were carried through perchloric acid precipitation and water dialysis steps, then dried in a Virtis
Freeze-Dryer and taken up in small amounts of water. Paper chromatography was carried out by methods previously described (11, 12 4A full fluorescent spectrum was run on each thrombocyte preparation superimposing this spectrum on that of the serotonin creatinine sulfate standard on an oscilloscopic screen. Identity of spectrum of the thrombocyte preparation with the standard spectrum was always observed. acid. Acid mucopolysaccharides were then precipitated by the addition of cetyl trimethyl ammonium bromide (13) and taken up in a small amount of 4 N hydrochloric acid. After eight hours of hydrolysis in sealed ampules in flowing steam, the sample was dried by gentle airjet in a jar containing solid sodium hydroxide, taken up in water and adjusted to pH 7.5 to 8.0 by addition of a trace of 0.1 N sodium hydroxide. Partial purification of hexosamines was then accomplished by passage over a Dowex 50 (H+ form) column.5 The final eluate was dried by airj et as before and taken up in a minute amount of water. The thrombocyte material and the chondroitin sulfate and hexosamine standard preparations were then hydrolyzed in sealed capillary tubes with equal volumes of 2 per cent ninhydrin in water containing 4 per cent pyridine at 1000 C. for 30 minutes (14) . The hydrolyzed materials were then chromatographed on Whatman No. 1 paper, descending, in isopropanol-water (9: 1)6 and developed by a modification 6 of the method of Trevelyan, Procter and Harrison (15), substituting 5 per cent aqueous sodium thiosulfate for 6 N ammonium hydroxide.
RESULTS
The average values for acid mucopolysaccharides (expressed as hexuronic acid) and 5-hydroxytryptamine recovered from human thrombocytes are recorded in Table I and are compared statistically. The differences noted and their significance are apparent on inspection of the table.
Hexuronic acid levels determined in parallel by the carbazole method and by the orcinol method in acid mucopolysaccharides of human thrombocytes and in various standard acid mucopolysaccharides are recorded in Table II (Figure 2 ). 7 All of the spots photographed were metachromatic as developed with toluidine blue except for a dark blue spot at each origin of the thrombocyte fraction. 8 The method used does not differentiate between glucosamine and mannosamine but does separate both of these substances from galactosamine.
DISCUSSION
The pattern of quantitative recovery of acid mucopolysaccharides from human thrombocytes differed from that of 5-hydroxytryptamine. The acid mucopolysaccharide content tended to vary with the amount of thrombocyte protein present per unit of blood, whereas the 5-hydroxytryptamine content tended toward constancy per unit of blood regardless of the amount of thrombocyte protein present.
The variation in level of acid mucopolysaccharides from human thrombocytes with the amount of thrombocyte protein present per unit of blood suggested that the acid mucopolysaccharides constituted a structural component of 3. On comparison of three groups of patients (noninflammatory, nonrheumatoid inflammatory and active rheumatoid), the thrombocyte protein level per unit of blood was significantly elevated in the inflammatory and rheumatoid groups, as was the acid mucopolysaccharide content of thrombocytes per unit of blood. The 5-hydroxytryptamine content of thrombocytes, in contrast, was slightly lower in the inflammatory and rheumatoid groups (and to a possibly significant degree in the rheumatoid group), despite the higher level of thrombocyte protein per unit of blood.
